Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PCPG | rs12243913 | chr10:131940860 | G/A | 0 | 175 | 25.4 | 25.97 | 3.17 | KM Plot |
| PCPG | rs12245378 | chr10:131944452 | A/G | 0 | 177 | 25.47 | 25.33 | 3.17 | KM Plot |
| PCPG | rs12245589 | chr10:131947044 | G/T | 0 | 177 | 25.47 | 24.47 | 3.17 | KM Plot |
| PCPG | rs12257157 | chr10:131955340 | A/T | 0 | 178 | 25.53 | 24.47 | 3.17 | KM Plot |
| PCPG | rs12258741 | chr10:131955339 | T/G | 0 | 178 | 25.53 | 24.47 | 3.17 | KM Plot |
| PCPG | rs12259027 | chr10:131940668 | C/T | 0 | 171 | 25.28 | 26.62 | 3.17 | KM Plot |
| PCPG | rs12261685 | chr10:131937286 | T/C | 0 | 175 | 25.47 | 25.33 | 3.17 | KM Plot |
| PCPG | rs12266862 | chr10:131937275 | G/A | 0 | 175 | 25.47 | 25.33 | 3.17 | KM Plot |
| PCPG | rs12266864 | chr10:131937283 | G/A | 0 | 175 | 25.47 | 25.33 | 3.17 | KM Plot |
| PCPG | rs12268200 | chr10:131981726 | A/G | 0 | 178 | 25.6 | 24.23 | 3.17 | KM Plot |
| PCPG | rs12268797 | chr10:131941860 | A/G | 0 | 174 | 25.47 | 25.97 | 3.17 | KM Plot |
| PCPG | rs12292442 | chr11:3235719 | A/G | 7.06E-5 | 171 | 25.53 | 27.13 | 14.82 | KM Plot |
| PCPG | rs12292649 | chr11:46257757 | C/T | 7.01E-5 | 175 | 25 | 25.97 | 25.4 | KM Plot |
| PCPG | rs12305929 | chr12:53500660 | A/G | 1.19E-10 | 174 | 25.17 | 26.57 | 3.05 | KM Plot |
| PCPG | rs12325805 | chr17:6912219 | T/G | 0.000302 | 173 | 25.87 | 25 | 4.17 | KM Plot |